Armata Pharmaceuticals Inc (ARMP)
2.87
+0.01
(+0.35%)
USD |
NYAM |
Jun 13, 16:00
2.93
+0.06
(+2.09%)
After-Hours: 20:00
Armata Pharmaceuticals Free Cash Flow: -46.82M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
March 31, 2024 | -46.82M |
December 31, 2023 | -55.57M |
September 30, 2023 | -55.09M |
June 30, 2023 | -53.52M |
March 31, 2023 | -50.52M |
December 31, 2022 | -34.69M |
September 30, 2022 | -33.49M |
June 30, 2022 | -27.41M |
March 31, 2022 | -22.86M |
December 31, 2021 | -24.88M |
September 30, 2021 | -22.72M |
June 30, 2021 | -21.14M |
March 31, 2021 | -20.53M |
December 31, 2020 | -19.09M |
September 30, 2020 | -15.18M |
June 30, 2020 | -15.72M |
March 31, 2020 | -17.54M |
December 31, 2019 | -15.81M |
September 30, 2019 | -14.57M |
June 30, 2019 | -12.24M |
March 31, 2019 | -8.491M |
December 31, 2018 | -9.426M |
September 30, 2018 | -10.30M |
June 30, 2018 | -8.753M |
March 31, 2018 | -9.482M |
Date | Value |
---|---|
December 31, 2017 | -9.25M |
September 30, 2017 | -8.374M |
June 30, 2017 | -10.91M |
March 31, 2017 | -10.99M |
December 31, 2016 | -10.88M |
September 30, 2016 | -11.74M |
June 30, 2016 | -11.19M |
March 31, 2016 | -10.85M |
December 31, 2015 | -9.991M |
September 30, 2015 | -10.83M |
June 30, 2015 | -10.98M |
March 31, 2015 | -12.19M |
December 31, 2014 | -13.77M |
September 30, 2014 | -11.99M |
June 30, 2014 | -11.75M |
March 31, 2014 | -9.195M |
December 31, 2013 | -6.394M |
September 30, 2013 | -3.73M |
June 30, 2013 | -2.651M |
March 31, 2013 | -2.619M |
September 30, 2009 | -5.467M |
June 30, 2009 | -10.05M |
March 31, 2009 | -8.764M |
December 31, 2008 | -11.04M |
September 30, 2008 | -11.00M |
Free Cash Flow Range, Past 5 Years
-55.57M
Minimum
Dec 2023
-12.24M
Maximum
Jun 2019
-28.97M
Average
-22.79M
Median
Free Cash Flow Benchmarks
AIM ImmunoTech Inc | -23.04M |
Perspective Therapeutics Inc | -23.28M |
Protalix BioTherapeutics Inc | 4.369M |
Electromed Inc | 4.787M |
Xtant Medical Holdings Inc | -14.80M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -10.58M |
Cash from Investing (Quarterly) | -0.25M |
Cash from Financing (Quarterly) | 34.93M |
Free Cash Flow Per Share (Quarterly) | -0.2999 |
Free Cash Flow Yield | -38.77% |